T. Rowe Price Investment Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$134M Buy
11,644,496
+2,426,680
+26% +$34.2M 0.09% 211
2025
Q4
$132M Buy
9,217,816
+910,320
+11% +$15.7M 0.08% 215
2025
Q3
$157M Sell
8,307,496
-4,343,766
-34% -$71.6M 0.1% 207
2025
Q2
$271M Buy
12,651,262
+825,017
+7% +$12.3M 0.17% 142
2025
Q1
$155M Buy
11,826,245
+467,301
+4% +$6.94M 0.1% 205
2024
Q4
$153M Sell
11,358,944
-302,122
-3% -$4.86M 0.09% 218
2024
Q3
$247M Buy
11,661,066
+375,471
+3% +$6.76M 0.15% 161
2024
Q2
$179M Buy
11,285,595
+2,742,749
+32% +$50.4M 0.11% 194
2024
Q1
$127M Buy
+8,542,846
New +$117M 0.08% 252

Other funds holding OSCR

T. Rowe Price Investment Management's OSCR Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its Oscar Health (OSCR) stake by 26% in Q1 2026, buying an estimated $34.2M and bringing the position to 11,644,496 shares worth $134M. The position accounts for 0.09% of the portfolio, ranked #211.

T. Rowe Price Investment Management first reported a position in OSCR in Q1 2024 and has held it in 9 quarters since. The position peaked at $271M in Q2 2025. 331 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • T. Rowe Price Investment Management held 11,644,496 shares of Oscar Health worth $134M as of Q1 2026.
  • T. Rowe Price Investment Management bought 2,426,680 Oscar Health shares in Q1 2026, an estimated $34.2M.
  • Oscar Health made up 0.09% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #211 holding.
  • T. Rowe Price Investment Management first reported a position in Oscar Health in Q1 2024 and has held it in 9 quarters since.
  • T. Rowe Price Investment Management's Oscar Health position peaked at $271M in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.